High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity

P Hoskin, A Rojas, P Ostler, R Hughes, R Alonzi… - Radiotherapy and …, 2014 - Elsevier
Background To evaluate early urinary (GU) and gastrointestinal (GI) adverse events (AEs)
after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced prostate …
被引用次数：90 相关文章

[引用][C] High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity

P Hoskin, A Rojas, P Ostler, R Hughes… - Radiotherapy and …, 2014 - cir.nii.ac.jp
High-dose-rate brachytherapy alone given as two or one fraction to patients for locally
advanced prostate cancer: Acute toxicity | CiNii Research CiNii 国立情報学研究所 学術情報 …

High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity

P Hoskin, A Rojas, P Ostler, R Hughes… - Radiotherapy and …, 2014 - inis.iaea.org
[en] Background: To evaluate early urinary (GU) and gastrointestinal (GI) adverse events
(AEs) after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced …

High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity

P Hoskin, A Rojas, P Ostler, R Hughes, R Alonzi… - Radiotherapy and …, 2014 - infona.pl
To evaluate early urinary (GU) and gastrointestinal (GI) adverse events (AEs) after two or
one fraction of high-dose rate brachytherapy (HDR-BT) in advanced prostate cancer. 165 …

High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity

P Hoskin, A Rojas, P Ostler, R Hughes… - Radiotherapy and …, 2014 - thegreenjournal.com
Background To evaluate early urinary (GU) and gastrointestinal (GI) adverse events (AEs)
after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced prostate …

High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity

P Hoskin, A Rojas, P Ostler… - … : journal of the …, 2014 - research.manchester.ac.uk
BACKGROUND: To evaluate early urinary (GU) and gastrointestinal (GI) adverse events
(AEs) after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced …

High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity

P Hoskin, A Rojas, P Ostler… - … : journal of the …, 2014 - pubmed.ncbi.nlm.nih.gov
Background To evaluate early urinary (GU) and gastrointestinal (GI) adverse events (AEs)
after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced prostate …

High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: acute toxicity.

P Hoskin, A Rojas, P Ostler, R Hughes… - … Oncology: Journal of …, 2013 - europepmc.org
High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced
prostate cancer: acute toxicity. - Abstract - Europe PMC Sign in | Create an account …

High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity

P Hoskin, A Rojas, P Ostler, R Hughes, R Alonzi… - Radiotherapy and …, 2014 - osti.gov
Background: To evaluate early urinary (GU) and gastrointestinal (GI) adverse events (AEs)
after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced prostate …